On 04 May, Adar Poonawalla, CEO of Serum Institute of India, announced coronavirus vaccine ‘Covovax’ is available for everyone above 12 years. Now, Covovax is...
The Drugs Controller General of India (DCGI) granted permission to Bharat Biotech to start conducting booster dose trials for its intranasal coronavirus vaccine. The approval...
AstraZeneca coronavirus vaccine registered 74 per cent efficacy at stopping vital diseases, according to the company’s US clinical trial results. The data was tested on...